Simultaneous cross-linking of CD6 and CD28 induces cell proliferation in resting T cells

Immunology

Volumn 93, Issue 3, 1998, Pages 358-365

  Osorio, L M ^a   Rottenberg, M ^a   Jondal, M ^a   Chow, S C ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD6 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD3; CARCINOGENS; CELL DIVISION; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDOLES; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALEIMIDES; PROTEIN KINASE C; RNA, MESSENGER; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE;

EID: 0031889830     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00442.x     Document Type: Article

References (34)

1. JANEWAY JR C.A. & BOTTOMLY K. (1996) Responses of T cells to ligands for the T-cell receptor. Semin Immunol 8, 109.
2. SHARPE A.H. (1995) Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout' mice. Curr Opin Immunol 7, 389.
3. BJORNDAHL J.M., SUNG S.S.J., HANSEN J.A. & FU S.M. (1989) Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies. Eur J Immunol 19, 881.
4. GANGEMI R.M.R., SWACK J.A., GAVIRIA D.M. & ROMAIN P.L. (1989) Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes. J Immunol 143, 2439.
5. BOTT C.M., DOSHI J.B., MORIMOTO C., ROMAIN P.L. & FOX D.A. (1993) Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein. Int Immunol 5, 783.
6. OSORIO L.M., GARCIA C.A., JONDAL M. & CHOW S.C. (1994) The anti-CD6 mab, JOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation. Cell Immunol 154, 123.
7. REINHERZ E.L., MEUER S.C., FITZGERALD K.A., HUSSEY R.E., LEVINE H. & SCHLOSSMAN S.F. (1982) Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex. Cell 30, 735.
8. REITER, C. (1989) White cell differentiation antigens. In: Leukocyte Typing IV, (eds W. Knapp, B. Dorken, E. P. Gilks et al.) pp. 339. Oxford University Press, New York.
9. ENDRES N., RIETHMULLER G. & RIEBER E.P. (1989) White cell differentiation antigens. In: Leukocyte Typing IV (eds W. Knapp, B. Dorken, E. P. Gilks et al.) p. 340. Oxford University Press, New York.
10. WEE S.F., WANG W.C., FARR A.G. et al. (1994) Characterization of a CD6 ligand (s) expressed on human- and murine- derived cell lines and murine lymphoid tissues. Cell Immunol 158, 353.
11. PATEL D. D. WEE S.F., WHICHARD L.P. et al. (1995) Identification and characterization of a 100-kd ligand for CD6 on human thymic epithelial cells. J Exp Med 181, 1563.
12. BOWEN M.A., PATEL D.D. LI X. et al. (1995) Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 181, 2213.
13. SWACK J.A., GANGEMI R.M.R., RUDD C.E., MORIMOTO C., SCHLOSSMAN S.F. & ROMAIN P.L. (1989) Structural characterization of CD6: properties of two distinct epitopes involved in T cell activation. Mol Immunol 26, 1037.
14. OSORIO L.M., ORDONEZ, C., GARCIA C.A., JONDAL M. & CHOW S.C. (1995) Evidence for protein tyrosine kinase involvement in CD6-induced T cell proliferation. Cell Immunol 166, 44.
15. JUNE C.H., LEDBETTER J.A., LINSLEY P.S. & THOMPSON C.B. (1990) Role of the CD28 receptor in T-cell activation. Immunol Today 11, 211.
16. RUDD C.E., JANSSEN O. CAI Y.C., DA SILVA A.J., RAAB M. & PRASAD K.V.S. (1994) Two step TCRzeta/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol Today 15, 225.
17. FRASER J.D., IRVING B.A., CRABTREE G.R. & WEISS A. (1991) Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251, 313.
18. WEISS A., MANGER B. & IMBODEN J. (1986) Synergy between the T3/antigen receptor complex and TP44 in the activation of human T cells. J Immunol 137, 819.
19. THOMPSON C.B., LINDSTEN T., LEDBETTER J.A. et al. (1989) CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci USA 86, 1333.
20. LU Y., GRANELLIPIPERNO A., BJORNDAHL J.M., PHILLIPS C.A. & TREVILLYAN J.M. (1992) CD28-induced T cell activation: evidence for a protein-tyrosine kinase signal transduction pathway. J Immunol 149, 24.
21. MORIMOTO C., RUDD C.E., LETVIN N.L., HAGAN M. & SCHLOSSMAN S.F. (1988) 2H1 - a novel antigen involved in T lymphocyte triggering. J Immunol 140, 2165.
22. CHOMCZYNSKI P. & SACCHI N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156.
23. PISA E.K., PISA P., HANSSON M. & WIGZELL H. (1992) OKT3-induced cytokine mRNA expression in human peripheral blood mononuclear cells measured by polymerase chain reaction. Scand J Immunol 36, 745.
24. LEDBETTER J.A., IMBODEN J.B., SCHIEVEN G.L. et al. (1990) CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood 75, 1531.
25. DIANZANI U., SHAW A., ALRAMADI B.K., KUBO R.T. & JANEWAY JR C.A. (1992) Physical association of CD4 with the T cell receptor. J Immunol 148, 678.
26. JUNE C.H., LEDBETTER J.A., GILLESPIE M.M., LINDSTEN T. & THOMPSON C.B. (1987) T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol 7, 4472.
27. COURAGE C., BUDWORTH J. & GESCHER A. (1995) Comparison of ability of protein kinase c inhibitors to arrest cell growth and to alter cellular protein kinase c localisation. Br J Cancer 71, 697.
28. COURAGE C., SNOWDEN R. & GESCHER A. (1996) Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells. Br J Cancer 74, 1199.
29. WARD S.G., JUNE C.H. & OLIVE D. (1996) PI 3-kinase: a pivotal pathway in T-cell activation? Immunol Today 17, 187.
30. TRUITT K. E. SHI J., GIBSON S., SEGAL L.G., MILLS G.B. & IMBODEN J.B. (1995) CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase. J Immunol 155, 4702.
31. KUNZ J. & HALL M.N. (1993) Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. TIBS 18, 334.
32. VERWILGHEN J., VANDENBERGHE P., WALLAYS G. et al. (1993) Simultaneous ligation of CDS and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy. J Immunol 150, 835.
33. BOISE L.H., MINN A.J., NOEL P.J. et al. (1995) CD28 costimulation can promote T cell survival by enhancing the expression of bcl-x (1). Immunity 3, 87.
34. ZOCCHI M.R. & POGOI A. (1991) Activation of CD3 TCR negative human thymocytes via CD28 molecule. Cell Immunol 136, 105.